Treatment of Patients with Factor VIII and IX Inhibitors

• References

• 1 Nilsson IM, Hedner U. Immunosuppressive treatment in hemophiliacs with inhibitors to factor VIII and factor IX. Scand J Haematol 1976; 16: 369-82
• 2 Lusher JM, Shapiro SS, Palascak JE. et al.: Efficacy of prothrombin complex concentrates in hemophiliacs with antibodies for factor VIII. A multicenter trial. N Engl J Med 1980; 303: 421-25
• 3 Sjamsoedin LJM, Heijnen L, Mauser-Bunshcoten EP. et al.: The effect of activated prothrombin complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A randomised double-blind clinical trial. N Engl J Med 1981; 305: 717-21
• 4 Hedner U, Glazer S, Pingel K. et al Successful use of recombinant factor VIIa in a patient with severe hemophilia A during synovectomy. Lancet 1988; 2: 1193
• 5 Macik BG, Hohneker J, Roberts HR. et al.: Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor. Am J Hematol 1989; 32: 232-34
• 6 Birch K, Glazer S, Feldstedt M, Hedner U. Clinical results obtained so far with recombinant FVIIa. XX Int Congr World Fed Hemophilia, Athens. 1992 (abstract 160)
• 7 Giles AR, Mann KG, Nesheim ME. A combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses factor VIII in vivo. Br J Haematol 1988; 69: 491-97
• 8 Gomperts E, Lawrence J, Liu SL. et al.: Safety and efficacy studies of recombinant tissue factor. Thromb Haemostas 1991; 65: 677
• 9 Kernoff PBA, Thomas ND, Lilley PA. et al.: Clinical experience with polyelectrolyte fractionated porcine factor VIII concentrate in the treatment of haemophiliacs with antibodies for factor VIII. Blood 1984; 63: 31-41
• 10 Nilsson IM, Sundqvist SB, Freiburghaus C. Extracorporeal protein A-Sepharose and specific affinity chromatography for removal of antibodies. In: Factor VIII Inhibitors; AR Liss, New York: 1991. pp. 225-41
• 11 Gjörstrup P, Berntorp E, Larsson L, Nilsson IM. Kinetic aspects of the removal of IgG and inhibitors in hemophiliacs using protein A immunoadsorption. Vox Sang 1991; 61: 244-50
• 12 Nilsson IM. The management of hemophilia patients with inhibitors. Transfusion Med Rev 1992; 6: 285-93
• 13 Shapiro SS. Antibodies to blood coagulation factors. Clin Haematol 1979; 2: 207-14
• 14 Hultin MB, Shapiro SS, Bowman HS. et al.: Immunosuppressive therapy of factor VIII inhibitors. Blood 1976; 48: 95-108
• 15 Sultan Y, Kazatchkine MD, Maisonneuve O, Nydegger UR. Antiidiotypic suppression of autoantibodies to factor VIII (anti-hemo-philic factor) by high-dose intravenous gammaglobulin. Lancet 1984; 1: 765-68
• 16 Brackmann HH. Induced immunotolerance in factor VIII inhibitor patients. In: Factor VIII Inhibitors. Hoyer LW. (ed). AR Liss; New York: 1984. pp. 181-95
• 17 Brackmann HH. 16 years experience with the immuntolerance induction in hemophilia patients at the Bonn Hemophilia Center. XX Int Congr World Fed Hemophilia, Athens. 1992 (abstract 12)
• 18 Mauser-Bunschoten EP, Nilsson IM, Kasper CK. Immune tolerance, a 1990 approach. In: Hemophilia and von Willebrand's Disease in the 1990s. Lusher JM, Kessler CM. (eds) Elsevier Science; New York: 1991. pp. 265-69
• 19 Aznar JA, Jorquera JI, Pieró A. et al.: The importance of corticoids added to continued treatment with factor VIII concentrates in the suppression of inhibitors in hemophilia A. Thromb Haemostas 1984; 51: 217-21
• 20 Ewing NP, Sanders NL, Dietrich SL. et al.: Induction of immune tolerance to factor VIII in hemophiliacs with inhibitors. JAMA 1988; 259: 65-68
• 21 Nilsson IM, Sundqvist SB, Ljung R. et al.: Suppression of secondary antibody by intravenous immunoglobulin in a patient with hemophilia B and antibodies. Scand J Haematol 1983; 30: 458-64
• 22 Nilsson IM, Berntorp E, Zettervall O. Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies. Proc Natl Acad Sci USA 1986; 83: 169-73
• 23 Nilsson IM, Berntorp E, Zettervall O. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII. N Engl J Med 1988; 318: 947-50
• 24 Nilsson IM, Berntorp E, Zettervall O, Dahlbäck B. Noncoagulation inhibitory factor VIII antibodies after induction of tolerance to factor VIII in hemophilia A patients. Blood 1990; 75: 378-83